GlycoMimetics, Inc. (GLYC) has a market capitalization of $1.01B and trades at $15.71. The 52-week range is 0.153-63.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-12,818.00.
The stock has a beta of 1.60, operates in the Healthcare sector.
